BDBM294718 US10112899, Example 195

SMILES: COc1c(F)cccc1C(=O)N1Cc2c(C1)c(C)c(-c1cc(F)c3OCCCc3c1C)c([C@H](OC(C)(C)C)C(O)=O)c2C

InChI Key: InChIKey=VVLUWGQDEIDFMG-HKBQPEDESA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 294718   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Human immunodeficiency virus type 1 integrase (Human immunodeficiency virus 1)	BDBM294718 (US10112899, Example 195) Show SMILES COc1c(F)cccc1C(=O)N1Cc2c(C1)c(C)c(-c1cc(F)c3OCCCc3c1C)c([C@H](OC(C)(C)C)C(O)=O)c2C |r,wD:32.36,(-3.98,-8.51,;-3.21,-7.17,;-3.98,-5.84,;-5.52,-5.84,;-6.29,-7.17,;-6.29,-4.51,;-5.52,-3.17,;-3.98,-3.17,;-3.21,-4.51,;-1.67,-4.51,;-.9,-5.84,;-.9,-3.17,;.63,-3.01,;.95,-1.5,;-.38,-.73,;-1.52,-1.76,;-.38,.81,;-1.71,1.58,;.95,1.58,;.95,3.12,;2.29,3.89,;2.29,5.43,;3.62,6.2,;.95,6.2,;.95,7.74,;-.38,8.51,;-1.71,7.74,;-1.71,6.2,;-.38,5.43,;-.38,3.89,;-1.71,3.12,;2.29,.81,;3.62,1.58,;3.62,3.12,;4.95,3.89,;4.95,5.43,;6.29,3.12,;6.29,4.66,;4.95,.81,;6.29,1.58,;4.95,-.73,;2.29,-.73,;3.62,-1.5,)| Show InChI InChI=1S/C34H37F2NO6/c1-17-20-11-9-13-42-30(20)26(36)14-22(17)27-18(2)23-15-37(32(38)21-10-8-12-25(35)29(21)41-7)16-24(23)19(3)28(27)31(33(39)40)43-34(4,5)6/h8,10,12,14,31H,9,11,13,15-16H2,1-7H3,(H,39,40)/t31-/m0/s1	PDB MMDB UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	n/a	n/a
ViiV HEALTHCARE UK LIMITED US Patent					Assay Description Antiviral HIV activity and cytotoxicity values for compounds of the invention from Table 1 were measured in parallel in the HTLV-1 transformed cell l...				US Patent US10112899 (2018) BindingDB Entry DOI: 10.7270/Q2KP8465
					More data for this Ligand-Target Pair